Volume 21 (2012)

Get Adobe ReaderSome of the documents on this page are in Adobe PDF format. To view these files you will need the free Adobe Reader. Download Adobe Reader(external link)

Return to volumes listing

Number Date Topics Covered
01 March 2012
  • Low dose Vit D
  • Fultium D3 
  • High dose Vit D 
  • SMBG 
  • GlucoRx Nexus meter accuracy 
  • NPSA Insulin passports 
  • Lipitor chewable tab
02 April 2012
  • Allergic Rhinitis update
  • Intranasal corticosteroids
  • Oral antihistamines 3
  • Grazax vaccine 4
  • Dabigatran Prescribing Update
  • AquADEKS for children with Cystic Fibrosis
03 June 2012
  • Information about the launch of the revised ONPOS wound care formulary phase 2 
  • Appendix 1: removal of foams from the wound management formulary
04 June 2012
  • Oxfordshire CCG Statement on the use of Dabigatran (▼Pradaxa®) and Rivaroxaban (▼ Xarelto®) in the Prevention of Stroke and Systemic Embolism in Adult Patients with Non valvular Atrial Fibrillation
05 July 2012
  • Drug patent expiries in 2012
  • Hypromellose PF eye drops
  • Buccolam—buccal midazolam, Hyoscine butylbromide/hydrobromide , Metolazone withdrawal
  • Potential interaction – simvastatin and amlodipine 
  • Citalopram drug interactions, orodispersible triptans
  • Branded generic savings, Ibandronic acid, Gliclazide MR, Intranet update
06 August 2012
  • Details of the implementation plan in Oxfordshire for the NPSA alert – The adult patient’s passport to safer use of insulin
07 September 2012 
  • Simvastatin – updated interaction guidance from MHRA 
  • What to do about it?
  • Example of patient letter
12 January  2012
  • Hypertension. This issue covers updated guidance in the management of hypertension in light of NICE CG 127 and recommendations of the Oxfordshire Area Prescribing Committee November 2011
13 February 2012
  • Waste audit results
  • What can we do to reduce waste primary care? 
  • South Central medicines waste campaign 
  • Reducing waste at OUH

 

Return to volumes listing

Copyright 2017 © Oxfordshire Clinical Commissioning Group